Charlotte V Elder

No ORCID on file · 3 papers in corpus
observational 2026
International journal of transgender health ·doi:10.1080/26895269.2024.2403140

BACKGROUND: The cessation of menstruation is a common and desired outcome of testosterone gender-affirming hormone therapy (GAHT), for trans and gender diverse (collectively referred to as trans) individuals recorded female at birth. This s…

observational 2024
International journal of transgender health ·doi:10.1080/26895269.2024.2392685

BACKGROUND: High rates of pelvic pain have been reported in trans individuals on testosterone, but the pathophysiology of pain and the potential role of testosterone are unclear. AIMS: The aim of this exploratory study was to determine whe…

observational 2023
LGBT health ·doi:10.1089/lgbt.2022.0187

Purpose: This descriptive study aimed to assess the characteristics of pelvic pain and explore predictive factors for pelvic pain in transgender (trans) individuals using testosterone therapy. Methods: An online cross-sectional survey was o…